| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Keith Fluegg. Overlooking relevant confounders in the assessment of pesticides and human health: a reply to Mostafalou and Abdollahi. Archives of toxicology. vol 91. issue 2. 2017-07-13. PMID:28032142. |
recently, we published evidence suggesting use of the herbicide, glyphosate, may predict health care utilization for attention-deficit hyperactivity disorder (adhd), a neurodevelopmental disorder that is characterized by cognitive impairments leading to attention deficits, impulsivity, and hyperactivity. |
2017-07-13 |
2023-08-13 |
human |
| Jilly Naaijen, Saskia de Ruiter, Marcel P Zwiers, Jeffrey C Glennon, Sarah Durston, David J Lythgoe, Steven C R Williams, Tobias Banaschewski, Daniel Brandeis, Barbara Franke, Jan K Buitelaa. COMPULS: design of a multicenter phenotypic, cognitive, genetic, and magnetic resonance imaging study in children with compulsive syndromes. BMC psychiatry. vol 16. issue 1. 2017-06-09. PMID:27782808. |
compulsivity, the closely linked trait impulsivity and addictive behaviour are associated with several neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (adhd), autism spectrum disorder (asd), and obsessive compulsive disorder (ocd). |
2017-06-09 |
2023-08-13 |
Not clear |
| Masahide Usam. Functional consequences of attention-deficit hyperactivity disorder on children and their families. Psychiatry and clinical neurosciences. vol 70. issue 8. 2017-02-13. PMID:27061213. |
attention-deficit hyperactivity disorder (adhd) is a neurodevelopmental disorder with core symptoms that include hyperactivity, impulsiveness, and inattention, and it is the most common psychiatric disorder among children and adolescents. |
2017-02-13 |
2023-08-13 |
Not clear |
| Beatrice Mörstedt, Salvatore Corbisiero, Hannes Bitto, Rolf-Dieter Stieglit. Emotional symptoms and their contribution to functional impairment in adults with attention-deficit/hyperactivity disorder. Attention deficit and hyperactivity disorders. vol 8. issue 1. 2016-12-13. PMID:26254914. |
attention-deficit/hyperactivity disorder (adhd) is a severe neurodevelopmental disorder beginning in childhood and consisting of the core symptoms of inattention, hyperactivity, and impulsivity. |
2016-12-13 |
2023-08-13 |
human |
| Chrislean Jun Botanas, Hyelim Lee, June Bryan de la Peña, Irene Joy Dela Peña, Taeseon Woo, Hee Jin Kim, Doug Hyun Han, Bung-Nyun Kim, Jae Hoon Cheon. Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder. Physiology & behavior. vol 155. 2016-10-17. PMID:26656767. |
attention-deficit hyperactivity disorder (adhd) is a prevalent neurodevelopmental disorder, characterized by symptoms of hyperactivity, inattention, and impulsivity. |
2016-10-17 |
2023-08-13 |
rat |
| Miki Kaneko, Yushiro Yamashita, Keiji Iramin. Quantitative Evaluation System of Soft Neurological Signs for Children with Attention Deficit Hyperactivity Disorder. Sensors (Basel, Switzerland). vol 16. issue 1. 2016-09-01. PMID:26797613. |
attention deficit hyperactivity disorder (adhd) is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. |
2016-09-01 |
2023-08-13 |
human |
| Amira Mohammed Osman, Ilham Mohammed Omer, Abdalla Abderahman Mohammed, Sanaa Eltahir Abdall. The prevalence and factors affecting attention deficit hyperactivity disorder among school children in Khartoum State. Sudanese journal of paediatrics. vol 15. issue 2. 2016-08-05. PMID:27493433. |
attention deficit hyperactivity disorder (adhd) is one of the most common neurodevelopmental disorders in children, characterized by age-inappropriate features of inattention, hyperactivity and impulsivity or both. |
2016-08-05 |
2023-08-13 |
Not clear |
| Kenneth S Koblan, Seth C Hopkins, Kaushik Sarma, Fengbin Jin, Robert Goldman, Scott H Kollins, Antony Loebe. Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 12. 2016-08-02. PMID:25948101. |
attention-deficit/hyperactivity disorder (adhd) is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity associated with clinically significant impairment in functioning. |
2016-08-02 |
2023-08-13 |
Not clear |
| Aida Bikic, James F Leckman, Jane Lindschou, Torben Ø Christensen, Søren Dalsgaar. Cognitive computer training in children with attention deficit hyperactivity disorder (ADHD) versus no intervention: study protocol for a randomized controlled trial. Trials. vol 16. 2016-07-11. PMID:26499057. |
attention deficit hyperactivity disorder (adhd) is a common neurodevelopmental disorder characterized by symptoms of inattention and impulsivity and/or hyperactivity and a range of cognitive dysfunctions. |
2016-07-11 |
2023-08-13 |
Not clear |
| Mercedeh Samiei, Reza Daneshmand, Rasul Keramatfar, Katayoon Khooshabi, Nasrin Amiri, Yadollah Farhadi, Seyedeh Zeinab Farzadfard, Hamid Kachooi, Roya Samad. Attention Deficit Hyper Activity Disorder (ADHD) and Stress: A Mutual Relationship between Children and Mothers. Basic and clinical neuroscience. vol 6. issue 2. 2016-06-16. PMID:27307956. |
attention deficit hyperactivity disorder (adhd) is a neurodevelopmental disorder characterized by high levels of inattention, hyperactivity and impulsivity which may result in mothers' stress. |
2016-06-16 |
2023-08-13 |
Not clear |
| Michelle Richardson, Darren A Moore, Ruth Gwernan-Jones, Jo Thompson-Coon, Obioha Ukoumunne, Morwenna Rogers, Rebecca Whear, Tamsin V Newlove-Delgado, Stuart Logan, Christopher Morris, Eric Taylor, Paul Cooper, Ken Stein, Ruth Garside, Tamsin J For. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research. Health technology assessment (Winchester, England). vol 19. issue 45. 2016-04-01. PMID:26129788. |
attention-deficit/hyperactivity disorder (adhd) is a neurodevelopmental disorder characterised by age-inappropriate levels of inattention, impulsivity and hyperactivity. |
2016-04-01 |
2023-08-13 |
Not clear |
| Jose Martinez-Badía, Jose Martinez-Rag. Who says this is a modern disorder? The early history of attention deficit hyperactivity disorder. World journal of psychiatry. vol 5. issue 4. 2016-01-07. PMID:26740929. |
attention-deficit hyperactivity disorder (adhd) is a complex, heterogeneous and multifactorial neurodevelopmental disorder characterized by persistent symptoms of inattention, hyperactivity and impulsivity. |
2016-01-07 |
2023-08-13 |
human |
| K M Clements, I M Devonshire, J N J Reynolds, P G Overto. Enhanced visual responses in the superior colliculus in an animal model of attention-deficit hyperactivity disorder and their suppression by D-amphetamine. Neuroscience. vol 274. 2015-10-15. PMID:24905438. |
attention-deficit hyperactivity disorder (adhd) is a prevalent neurodevelopmental disorder characterized by overactivity, impulsiveness and attentional problems, including an increase in distractibility. |
2015-10-15 |
2023-08-13 |
rat |
| Anthony L Rostain, J Russell Ramsay, Roberta Wait. Culturally competent strategies for assessing and treating ADHD in African American adults. The Journal of clinical psychiatry. vol 76. issue 5. 2015-08-11. PMID:26035187. |
attention-deficit/hyperactivity disorder (adhd) is a neurodevelopmental disorder associated with symptoms of inattention, hyperactivity, and impulsivity. |
2015-08-11 |
2023-08-13 |
Not clear |
| Lisa L Weyandt, Danielle R Oster, Marisa E Marraccini, Bergljot Gyda Gudmundsdottir, Bailey A Munro, Brynheld Martinez Zavras, Ben Kuha. Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants. Psychology research and behavior management. vol 7. 2014-09-17. PMID:25228824. |
attention-deficit/hyperactivity disorder (adhd) is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity that cause functional impairment. |
2014-09-17 |
2023-08-13 |
Not clear |
| Lisa Weyandt, Anthony Swentosky, Bergljot Gyda Gudmundsdotti. Neuroimaging and ADHD: fMRI, PET, DTI findings, and methodological limitations. Developmental neuropsychology. vol 38. issue 4. 2013-12-19. PMID:23682662. |
attention deficit hyperactivity disorder (adhd) is a neurodevelopmental disorder characterized by pervasive and developmentally inappropriate levels of inattention, impulsivity, and hyperactivity. |
2013-12-19 |
2023-08-12 |
Not clear |
| Jose Martinez-Raga, Carlos Knecht, Nestor Szerman, María I Martine. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS drugs. vol 27. issue 1. 2013-07-03. PMID:23160939. |
attention-deficit hyperactivity disorder (adhd) is a chronic neurodevelopmental disorder characterized by persistent symptoms of inattention, hyperactivity and/or impulsivity. |
2013-07-03 |
2023-08-12 |
human |
| Isabelle Massat, Hichem Slama, Martin Kavec, Sylvie Linotte, Alison Mary, Daniele Baleriaux, Thierry Metens, Julien Mendlewicz, Philippe Peigneu. Working memory-related functional brain patterns in never medicated children with ADHD. PloS one. vol 7. issue 11. 2013-05-06. PMID:23166657. |
attention deficit/hyperactivity disorder (adhd) is a pervasive neurodevelopmental disorder characterized by 3 clusters of age-inappropriate cardinal symptoms: inattention, hyperactivity and impulsivity. |
2013-05-06 |
2023-08-12 |
Not clear |
| Suzanne McCarthy, Lynda Wilton, Macey L Murray, Paul Hodgkins, Philip Asherson, Ian C K Won. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC pediatrics. vol 12. 2013-04-01. PMID:22712630. |
attention deficit hyperactivity disorder (adhd) is a common neurodevelopmental disorder characterised by the symptoms of inattention, impulsivity and hyperactivity. |
2013-04-01 |
2023-08-12 |
Not clear |
| M Lange, W Norton, M Coolen, M Chaminade, S Merker, F Proft, A Schmitt, P Vernier, K-P Lesch, L Bally-Cui. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Molecular psychiatry. vol 17. issue 9. 2013-01-23. PMID:22508465. |
attention-deficit/hyperactivity disorder (adhd) is a neurodevelopmental disorder characterized by inattention, hyperactivity, increased impulsivity and emotion dysregulation. |
2013-01-23 |
2023-08-12 |
zebrafish |